PatientsVille.com Logo

PatientsVille

Minidril Side Effects

Common Minidril Side Effects


The most commonly reported Minidril side effects (click to view or check a box to report):

Pulmonary Embolism (4)
Deep Vein Thrombosis (3)
Chest Pain (2)
Influenza (2)
Cerebral Venous Thrombosis (2)
Anxiety (2)
Jugular Vein Thrombosis (2)
Cough (2)
Livedo Reticularis (2)
Subclavian Vein Thrombosis (2)
Pulmonary Infarction (2)
Phlebitis (2)
Lymphoedema (2)
Infarction (1)
Hemiplegia (1)
International Normalised Ratio Increased (1)
Musculoskeletal Chest Pain (1)
Migraine With Aura (1)
Mesenteric Vein Thrombosis (1)
Ischaemic Stroke (1)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Minidril Side Effects Reported to FDA

The following Minidril reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Minidril on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Transient Ischaemic Attack, Migraine With Aura, Hemianopia, Headache
This is a report of a 18-year-old female patient (weight: NA) from FR, suffering from the following symptoms/conditions: contraception, who was treated with Minidril (dosage: Unk, start time: 2013), combined with: NA. and developed a serious reaction and side effect(s). The consumer presented with:
  • Transient Ischaemic Attack
  • Migraine With Aura
  • Hemianopia
  • Headache
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Minidril treatment in female patients, resulting in transient ischaemic attack side effect. The patient was hospitalized.

Cardio-respiratory Arrest, Ventricular Fibrillation
This report suggests a potential Minidril Cardio-respiratory Arrest, Ventricular Fibrillation side effect(s) that can have serious consequences. A 22-year-old female patient (weight: NA) from FR was diagnosed with the following symptoms/conditions: contraception,acne and used Minidril (dosage: Unk) starting Oct 08, 2013. Soon after starting Minidril the patient began experiencing various side effects, including:
  • Cardio-respiratory Arrest
  • Ventricular Fibrillation
Drugs used concurrently:
  • Diane-35 (Unk)
  • Tetralysal (300 Mg, 2x/day)
  • Tetralysal (300 Mg, 1x/day)
  • Epiduo (2 Df (2 Applications), Daily)
  • Rubozinc (Unk)
  • Cod Liver Oil (Unk)
  • Bepanthene (Unk)
  • Effacne (Unk)
The patient was hospitalized. Although Minidril demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as cardio-respiratory arrest, may still occur.

Venous Thrombosis, Postpartum Venous Thrombosis
This Venous Thrombosis, Postpartum Venous Thrombosis problem was reported by a health professional from FR. A 24-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On NS this consumer started treatment with Minidril (dosage: NA). The following drugs were being taken at the same time:
  • Adepal
When commencing Minidril, the patient experienced the following unwanted symptoms/side effects:
  • Venous Thrombosis
  • Postpartum Venous Thrombosis
The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as venous thrombosis, may become evident only after a product is in use by the general population.

Amenorrhoea, Asthenia, Pain, Tinnitus, Vaginal Discharge, Somnolence, Depression, Pyrexia, Chills
This is a report of a 31-year-old female patient (weight: NA) from FR. The patient developed the following symptoms/conditions: menstrual cycle management and was treated with Minidril (dosage: (ethinylestradiol 30ug, Levonorgestrel 150ug), Unk) starting Jun 20, 2013. Concurrently used drugs: NA.Soon after that, the consumer experienced the following side effects:
  • Amenorrhoea
  • Asthenia
  • Pain
  • Tinnitus
  • Vaginal Discharge
  • Somnolence
  • Depression
  • Pyrexia
  • Chills
This opens a possibility that Minidril treatment could cause the above reactions, including amenorrhoea, and some female subjects may be more susceptible.


Acute Coronary Syndrome, Deep Vein Thrombosis
A 46-year-old female patient (weight: NA) from FR with the following symptoms/conditions: oral contraception,abnormal behaviour,epilepsy started Minidril treatment (dosage: Unk) on 2001. Soon after starting Minidril treatment, the subject experienced various side effects, including:
  • Acute Coronary Syndrome
  • Deep Vein Thrombosis
Concurrently used drugs:
  • Depamide
  • Depakine
The patient was hospitalized. This finding indicates that some female patients could be more vulnerable to Minidril.

Ischaemic Stroke, Carotid Artery Dissection
A 32-year-old female patient from FR (weight: NA) experienced symptoms, such as: oral contraception,tachycardia and was treated with Minidril(dosage: Unk). The treatment was initiated on Oct 31, 2012. After that a consumer reported the following side effect(s):
  • Ischaemic Stroke
  • Carotid Artery Dissection
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Minidril efficacy:
  • Nebivolol (Unk)
The patient was hospitalized.

Arterial Thrombosis, Renal Infarct
In this report, Minidril was administered for the following condition: oral contraception.A 20-year-old female consumer from FR (weight: NA) started Minidril treatment (dosage: Unk) on NS.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Arterial Thrombosis
  • Renal Infarct
A possible interaction with other drugs could have contributed to this reaction:
  • Jasmine (Unk)
The patient was hospitalized.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Minidril treatment could be related to the listed above side effect(s).

Dysaesthesia
This is a report of the following Minidril side effect(s):
  • Dysaesthesia
A 40-year-old female patient from FR (weight: NA) presented with the following condition: contraception and received a treatment with Minidril (dosage: (150ug, 30ug), Unk Cyclic) starting: 2001.The following concurrently used drugs could have generated interactions: NA.The patient was hospitalized.This report suggests that a Minidril treatment could be associated with the listed above side effect(s).

Arteriospasm Coronary
This Minidril report was submitted by a 46-year-old female consumer from FR (weight: NA). The patient was diagnosed with: oral contraception and Minidril was administered (dosage: 1 Df, 1x/day (ethinyl Estradiol 30ug/levonorgestrel 150ug)) starting: NS. The consumer developed a set of symptoms:
  • Arteriospasm Coronary
Other drugs used simultaneously: NA.The patient was hospitalized.Those unexpected symptoms could be linked to a Minidril treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Phlebitis, Pulmonary Embolism
This is a report of a possible correlation between Minidril use and the following symptoms/side effect(s):
  • Phlebitis
  • Pulmonary Embolism
which could contribute to an assessment of Minidril risk profile.A 21-year-old female consumer from FR (weight: NA) was suffering from contraception and was treated with Minidril (dosage: 1 Df, 1x/day According To Cycle) starting 200003.Other concurrent medications: NA.The patient was hospitalized.

Cerebral Infarction, Hemiplegia, Paraesthesia
A 43-year-old female patient from FR (weight: NA) presented with the following symptoms: contraception and after a treatment with Minidril (dosage: 1 Df (150ug, 30ug), 1x/day) experienced the following side effect(s):
  • Cerebral Infarction
  • Hemiplegia
  • Paraesthesia
The treatment was started on NS. Minidril was used in combination with the following drugs: NA.The patient was hospitalized.This report could alert potential Minidril consumers.

Cerebral Venous Thrombosis, Haemorrhagic Cerebral Infarction
In this report, a 36-year-old female patient from FR (weight: NA) was affected by a possible Minidril side effect.The patient was diagnosed with contraception. After a treatment with Minidril (dosage: 1 Df, 1x/day, start date: Oct 01, 2012), the patient experienced the following side effect(s):
  • Cerebral Venous Thrombosis
  • Haemorrhagic Cerebral Infarction
The following simultaneously used drugs could have led to this reaction: NA.The patient was hospitalized.The findings here stress that side effects should be taken into consideration when evaluating a Minidril treatment.

Pulmonary Embolism, Pulmonary Infarction
This is a report of a 29-year-old female patient from FR (weight: NA), who used Minidril (dosage: (150ug/ 30ug), Unk) for a treatment of oral contraception. After starting a treatment on 201203, the patient experienced the following side effect(s):
  • Pulmonary Embolism
  • Pulmonary Infarction
The following drugs could possibly have interacted with the Minidril treatment NA.The patient was hospitalized.Taken together, these observations suggest that a Minidril treatment could be related to side effect(s), such as Pulmonary Embolism, Pulmonary Infarction.

Cerebral Venous Thrombosis
This cerebral venous thrombosis side effect was reported by a health professional from FR. A 18-year-old female patient (weight:NA) experienced the following symptoms/conditions: contraception. The patient was prescribed Minidril (dosage: Ethinylestradiol 30 Ug/ Levonorgestrel 150 Ug), which was started on 201012. Concurrently used drugs: NA. When starting to take Minidril the consumer reported the following symptoms:
  • Cerebral Venous Thrombosis
The patient was hospitalized. These side effects may potentially be related to Minidril.

Pulmonary Embolism, Dyspnoea, Phlebitis, Musculoskeletal Chest Pain, Infarction
This is a Minidril side effect report of a 37-year-old female patient (weight:NA) from FR, suffering from the following symptoms/conditions: NA, who was treated with Minidril (dosage:Unk, start time: 200001), combined with:
  • Xarelto (Unk)
, and developed a serious reaction and a pulmonary embolism side effect. The patient presented with:
  • Pulmonary Embolism
  • Dyspnoea
  • Phlebitis
  • Musculoskeletal Chest Pain
  • Infarction
which developed after the beginning of treatment. The patient was hospitalized. This side effect report can indicate a possible existence of increased vulnerability to Minidril treatment in female patients suffering from NA, resulting in pulmonary embolism.

Mesenteric Vein Thrombosis, Splenic Vein Thrombosis, Abdominal Pain
This report suggests a potential Minidril mesenteric vein thrombosis side effect(s) that can have serious consequences. A 33-year-old female patient from FR (weight:NA) was diagnosed with the following health condition(s): contraception and used Minidril (dosage: 1 Df, 1x/day) starting 201210. Soon after starting Minidril the patient began experiencing various side effects, including:
  • Mesenteric Vein Thrombosis
  • Splenic Vein Thrombosis
  • Abdominal Pain
Drugs used concurrently:
  • Adepal (Unk)
The patient was hospitalized. Although Minidril demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as mesenteric vein thrombosis, may still occur.

Bone Infarction
This bone infarction problem was reported by a health professional from FR. A 17-year-old female patient (weight: NA) was diagnosed with the following medical condition(s): contraception,tachycardia.On 2010 a consumer started treatment with Minidril (dosage: 1 Df, 1x/day). The following drugs/medications were being taken at the same time:
  • Atenolol (25 Mg, 1x/day)
  • Procoralan (5 Mg, 2x/day)
  • Imigrane (Unk)
When commencing Minidril, the patient experienced the following unwanted symptoms /side effects:
  • Bone Infarction
The patient was hospitalized. Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as bone infarction, may become evident only after a product is in use by the general population.

Cough, Influenza, Jugular Vein Thrombosis, Lymphoedema, Subclavian Vein Thrombosis
This is a Minidril (levonorgestrel/ethinyl Estradiol, Tablet, 0) side effect report of a 36-year-old female patient (weight: NA) from FRANCE. The patient developed the following symptoms/conditions: oral contraception and was treated with Minidril (levonorgestrel/ethinyl Estradiol, Tablet, 0) (dosage: 1 Tablet 1x Per 1 Day Oral) starting NS. Concurrently used drugs: NA. Soon after that, the consumer experienced the following of symptoms:
  • Cough
  • Influenza
  • Jugular Vein Thrombosis
  • Lymphoedema
  • Subclavian Vein Thrombosis
The patient was hospitalized. This opens a possibility that Minidril (levonorgestrel/ethinyl Estradiol, Tablet, 0) could cause cough and that some female patients may be more susceptible.

Cytolytic Hepatitis
A 31-year-old female patient (weight: NA) from FRANCE with the following symptoms: NA started Minidril treatment (dosage: 1 Tablet 1x Per 1 Day Oral) on Jan 25, 2005. Soon after starting Minidril treatment, the consumer experienced several side effects, including:
  • Cytolytic Hepatitis
. Concurrently used drugs:
  • Vesanoid (72 Mg 1x Per 1 Day Oral)
  • Dexamethasone
  • Cytarabine
  • Elitek
  • Cerubidine
The patient was hospitalized. This finding indicates that some patients can be more vulnerable to developing Minidril side effects, such as cytolytic hepatitis.

Influenza, Jugular Vein Thrombosis, Lymphoedema, Subclavian Vein Thrombosis
This influenza side effect was reported by a consumer or non-health professional from FRANCE. A 36-year-old female patient (weight:NA) experienced the following symptoms/conditions: oral contraception.The patient was prescribed Minidril (levonorgestrel/ethinyl Estradiol, Tablet, 0) (dosage: 1 Tablet 1x Per 1 Day Oral), which was started on NS. Concurrently used drugs: NA..When starting to take Minidril (levonorgestrel/ethinyl Estradiol, Tablet, 0) the consumer reported symptoms, such as:
  • Influenza
  • Jugular Vein Thrombosis
  • Lymphoedema
  • Subclavian Vein Thrombosis
These side effects may potentially be related to Minidril (levonorgestrel/ethinyl Estradiol, Tablet, 0). The patient was hospitalized.

Activated Protein C Resistance, Anxiety, Chest Pain, Cough, Deep Vein Thrombosis, Dyspnoea Exertional, Electrocardiogram T Wave Inversion, Factor V Leiden Mutation, Fibrin D Dimer Increased
This is a report of a 32-year-old female patient (weight: NA) from FRANCE, suffering from the following symptoms/conditions: contraception, who was treated with Minidril (levonorgestrel/ethinyl Estradiol, Tablet, 0) Lot X05058 (dosage: 1 Tablet 1x Per 1 Day; Oral, start time: May 01, 2005), combined with: NA. and developed a serious reaction and side effect(s). The consumer presented with:
  • Activated Protein C Resistance
  • Anxiety
  • Chest Pain
  • Cough
  • Deep Vein Thrombosis
  • Dyspnoea Exertional
  • Electrocardiogram T Wave Inversion
  • Factor V Leiden Mutation
  • Fibrin D Dimer Increased
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Minidril (levonorgestrel/ethinyl Estradiol, Tablet, 0) Lot X05058 treatment in female patients, resulting in activated protein c resistance side effect. The patient was hospitalized and became disabled.

Anxiety, Body Temperature Increased, Chest Pain, Coagulation Test Abnormal, Deep Vein Thrombosis, Haemangioma Of Liver, International Normalised Ratio Increased, Pulmonary Embolism, Pulmonary Infarction
This report suggests a potential Minidril (levonorgestrel/ethinyl Estradiol, Tablet, 0) Lot No.: X05058 Anxiety, Body Temperature Increased, Chest Pain, Coagulation Test Abnormal, Deep Vein Thrombosis, Haemangioma Of Liver, International Normalised Ratio Increased, Pulmonary Embolism, Pulmonary Infarction side effect(s) that can have serious consequences. A 32-year-old female patient (weight: NA) from FRANCE was diagnosed with the following symptoms/conditions: contraception and used Minidril (levonorgestrel/ethinyl Estradiol, Tablet, 0) Lot No.: X05058 (dosage: 1 Tablet 1x Per 1 Day, Oral) starting May 01, 2005. Soon after starting Minidril (levonorgestrel/ethinyl Estradiol, Tablet, 0) Lot No.: X05058 the patient began experiencing various side effects, including:
  • Anxiety
  • Body Temperature Increased
  • Chest Pain
  • Coagulation Test Abnormal
  • Deep Vein Thrombosis
  • Haemangioma Of Liver
  • International Normalised Ratio Increased
  • Pulmonary Embolism
  • Pulmonary Infarction
Drugs used concurrently: NA.The patient was hospitalized and became disabled. Although Minidril (levonorgestrel/ethinyl Estradiol, Tablet, 0) Lot No.: X05058 demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as anxiety, may still occur.

Livedo Reticularis
This Livedo Reticularis problem was reported by a consumer or non-health professional from . A 38-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: contraception. On Dec 01, 2004 this consumer started treatment with Minidril (levonorgestrel/ethinyl Estradiol, Tablet, 0) (dosage: 1 Tablet 1x Per 1 Day, Oral; Long Term Treatment). The following drugs were being taken at the same time:
  • Ferrous Sulfate Tab (Oral)
When commencing Minidril (levonorgestrel/ethinyl Estradiol, Tablet, 0), the patient experienced the following unwanted symptoms/side effects:
  • Livedo Reticularis
The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as livedo reticularis, may become evident only after a product is in use by the general population.

Livedo Reticularis
This is a report of a 38-year-old female patient (weight: NA) from . The patient developed the following symptoms/conditions: contraception and was treated with Minidril (levonorgestrel/ethinyl Estradiol, Tablet, 0) (dosage: 1 Tablet 1x Per 1 Day Oral) starting NS. Concurrently used drugs:
  • Tardyferon (ferrous Sulfate, , 0) (Oral)
Soon after that, the consumer experienced the following side effects:
  • Livedo Reticularis
The patient was hospitalized. This opens a possibility that Minidril (levonorgestrel/ethinyl Estradiol, Tablet, 0) treatment could cause the above reactions, including livedo reticularis, and some female subjects may be more susceptible.



Top 10 Minidril Side Effects for Men

Men Side EffectsReports

Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Minidril Side Effects

    Did You Have a Minidril Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Minidril for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Minidril Safety Alerts, Active Ingredients, Usage Information

    More About Minidril

    Side Effects reported to FDA: 24

    Minidril safety alerts: No

    Reported deaths: 1

    Reported hospitalizations: 17

    Latest Minidril clinical trials